SCHEMBL287199

SCHEMBL287199

COc1ccnc(Cl)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29792641 1.00
Pyridine SCHEMBL28222133 0.89 CCR1 (0.50)
SCHEMBL191463 0.87 SMN1; SMN2 (0.50)
SCHEMBL191885 0.86 CCR1 (0.47)
SCHEMBL15832082 0.80 TRPA1 (0.50)
SCHEMBL27314075 0.80 GRM5 (0.48)
SCHEMBL30864880 0.80 GRM5 (0.48)
SCHEMBL26099232 0.80 APP (0.51)
SCHEMBL27032950 0.79 RECQL (0.41)
SCHEMBL17930597 0.79 DYRK1A (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 530 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113754579-A Preparation method of pyridine derivative 正大天晴药业集团股份有限公司 2021-12-07 CN claimed
CN-110813201-B Concentrated palladium colloid and preparation method and application thereof 苏州天承化工有限公司 2021-09-28 CN claimed
CN-111116460-A Synthesis method of 2-chloro-4-hydroxypyridine-3-formaldehyde hydrobromide 阿里生物新材料(常州)有限公司 2020-05-08 CN claimed
CN-110813201-A Concentrated palladium colloid and preparation method and application thereof 苏州天承化工有限公司 2020-02-21 CN claimed
CN-106751439-A Carbinol-modified pnenolic aldehyde foam material of a kind of 2 aminopyridine 4 and preparation method thereof 沈阳化工大学 2017-05-31 CN claimed
CN-103664766-B Preparation method of 2-aminopyridine-4-methyl alcohol UNIV ZHEJIANG 2015-06-24 CN claimed
CN-103664766-A Preparation method of 2-aminopyridine-4-methyl alcohol UNIV ZHEJIANG 2014-03-26 CN claimed
US-12636290-B2 BET inhibitors for modulating DUX4 expression in FSHD SAINT LOUIS UNIVERSITY (US) 2026-05-26 US disclosed
EP-4741018-A2 SULPHONAMIDE COMPOUNDS Anaxis Pharma Pty Ltd (AU) 2026-05-13 EP disclosed
EP-4142732-B1 METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS INC (US) 2026-04-22 EP disclosed
US-20260027096-A1 PHD INHIBITORS UNIV OXFORD INNOVATION LTD (GB) 2026-01-29 US disclosed
US-20250388593-A1 CEREBLON E3 LIGASE BINDING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PRODUCTION METHOD THEREFOR MITSUBISHI TANABE PHARMA CORPORATION (JP) 2025-12-25 US disclosed
EP-4655294-A1 PYRAZOLE DERIVSTIVES AS PHD INHIBITORS Oxford University Innovation Limited (GB) 2025-12-03 EP disclosed
WO-2002036570-A1 4-SUBSTITUTED QUINOLINES AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2002-05-10 WO disclosed
WO-2002004447-A1 VARIOLIN DERIVATIVES AS ANTI-CANCER AGENTS PHARMA MAR, S.A. (ES) 2002-01-17 WO disclosed
EP-1124821-A1 COMPOUNDS AstraZeneca AB (SE) 2001-08-22 EP disclosed
WO-2000027842-A1 COMPOUNDS ASTRAZENECA AB (SE) 2000-05-18 WO disclosed
US-5811540-A 5-O-pyrimidyl-2,3-dideoxy-1-thiofuranoside derivative, and production method and use thereof THE NOGUCHI INSTITUTE (JP) 1998-09-22 US disclosed
US-4472409-A ANTIULCER AGENTS BYK GULDEN LOMBERG CHEMISCHE FABRIK GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-09-18 US disclosed
EP-0080602-A1 Substituted benzimidazoles, process for their preparation, their use and medicaments containing them Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1983-06-08 EP disclosed